Dual-loss of PBRM1 and RAD51 identifies hyper-sensitive subset patients to immunotherapy in clear cell renal cell carcinoma Ziyang XuWenbin JiangJiejie Xu Research Open access 12 April 2024 Article: 95
Bifidobacterium modulation of tumor immunotherapy and its mechanism Bo PeiShixuan PengFuxiang Zhou Review Open access 02 April 2024 Article: 94
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma Konstantinos S. PapadakosGilar Gorji-BahriAnna M. Blom Research Open access 02 April 2024 Article: 93
Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapy Jhen-Yu ChenPo-Yu LinKevin Chih-Yang Huang Research Open access 02 April 2024 Article: 92
circFTO from M2 macrophage-derived small extracellular vesicles (sEV) enhances NSCLC malignancy by regulation miR-148a-3pPDK4 axis Qingtao LiuPei XuFangbao Ding Research Open access 30 March 2024 Article: 91
IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC models Justin YuJacob GadwaSana D. Karam Research Open access 30 March 2024 Article: 90
Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours Manish R. PatelMelissa JohnsonLillian L. Siu Research Open access 30 March 2024 Article: 89
Prenatal inflammation exposure accelerates lung cancer tumorigenesis in offspring mouse: possible links to IRE1α/XBP1-mediated M2-like polarization of TAMs and PD-L1 up-expression Jingbo MaJian TanKeqiang Liu Research Open access 30 March 2024 Article: 88
The radiomics nomogram predicts the prognosis of pancreatic cancer patients with hepatic metastasis after chemoimmunotherapy Wenxin LuGuangyu WuLiwei Wang Research Open access 30 March 2024 Article: 87
SFRP1 decreases WNT-Mediated M2 macrophage marker expression in breast tissue Kelly J. GregoryHolly MasonSallie S. Schneider Brief Report Open access 30 March 2024 Article: 86
TGF-β1 and TGF-βR1 variants are associated with clinical outcomes in smoking-related head and neck cancer patients treated with chemoradiation through modulating microRNA-mediated regulation Zihao NiuPeng SunGuojun Li Research Open access 30 March 2024 Article: 85
IL-2 promotes expansion and intratumoral accumulation of tumor infiltrating dendritic cells in pancreatic cancer Tingting GongXinyang HuangQi Wang Research Open access 30 March 2024 Article: 84
23-Hydroxybetulinic acid attenuates 5-fluorouracil resistance of colorectal cancer by modulating M2 macrophage polarization via STAT6 signaling Zeping FanYaru CuiWenbin Duan Research Open access 30 March 2024 Article: 83
DR30318, a novel tri-specific T cell engager for Claudin 18.2 positive cancers immunotherapy Zhe MaZhenxing ZhouLushan Yu Research Open access 30 March 2024 Article: 82
Characterization of a novel anti-PVRIG antibody with Fc-competent function that exerts strong antitumor effects via NK activation in preclinical models Hongyu XueZhimin ZhangKai Chen Research Open access 30 March 2024 Article: 81
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth Andrew N. WilkinsonRui ChenSherry Y. Wu Research Open access 30 March 2024 Article: 80
Efficacy of immune checkpoint inhibitors differs in various status of carcinoma: a study based on 29 cohorts with 3255 participants Chunlan WuYujun KeXianhe Xie Research Open access 30 March 2024 Article: 79
Lipid droplets-related Perilipin-3: potential immune checkpoint and oncogene in oral squamous cell carcinoma Yijia HeLingyun LiuLiang Ding Research Open access 30 March 2024 Article: 78
Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activity Jennifer W. CaoJessica LakeSteven Dow Research Open access 30 March 2024 Article: 77
PGRN inhibits CD8+T cell recruitment and promotes breast cancer progression by up-regulating ICAM-1 on TAM Ting ZhouHusun QianBianqin Guo Research Open access 30 March 2024 Article: 76